Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-008219
Filing Date
2024-12-19
Accepted
2024-12-19 17:29:43
Documents
85
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q upxi_10q.htm   iXBRL 10-Q 995342
2 CERTIFICATION upxi_ex311.htm EX-31.1 10212
3 CERTIFICATION upxi_ex312.htm EX-31.2 10010
4 CERTIFICATION upxi_ex321.htm EX-32.1 3929
5 CERTIFICATION upxi_ex322.htm EX-32.2 3986
  Complete submission text file 0001477932-24-008219.txt   5985811

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA upxi-20240930.xsd EX-101.SCH 69277
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20240930_lab.xml EX-101.LAB 367567
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20240930_cal.xml EX-101.CAL 67250
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20240930_pre.xml EX-101.PRE 312932
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20240930_def.xml EX-101.DEF 175006
88 EXTRACTED XBRL INSTANCE DOCUMENT upxi_10q_htm.xml XML 993404
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-40535 | Film No.: 241564310
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)